抗TIGIT抗体のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anti-TIGIT Antibody Market Insights and Forecast to 2028

• レポートコード：QY2203B09199
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の抗TIGIT抗体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗TIGIT抗体の世界市場のxxx％を占める「単剤療法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「細胞がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の抗TIGIT抗体の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗TIGIT抗体市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗TIGIT抗体市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

抗TIGIT抗体のグローバル主要メーカーには、Roche、Merck、AstraZeneca、Arcus、Astellas、BeiGene、BMS、Junshi Biosciences、Innovent Biologics、Mereo BioPharma、Seattle Genetics、Hengrui Medicine、Compugenなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

抗TIGIT抗体市場は、種類と用途によって区分されます。世界の抗TIGIT抗体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
単剤療法、併用療法

【用途別セグメント】
細胞がん、固形腫瘍

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 抗TIGIT抗体製品概要
- 種類別市場（単剤療法、併用療法）
- 用途別市場（細胞がん、固形腫瘍）
- 調査の目的
・エグゼクティブサマリー
- 世界の抗TIGIT抗体販売量予測2017-2028
- 世界の抗TIGIT抗体売上予測2017-2028
- 抗TIGIT抗体の地域別販売量
- 抗TIGIT抗体の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別抗TIGIT抗体販売量
- 主要メーカー別抗TIGIT抗体売上
- 主要メーカー別抗TIGIT抗体価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（単剤療法、併用療法）
- 抗TIGIT抗体の種類別販売量
- 抗TIGIT抗体の種類別売上
- 抗TIGIT抗体の種類別価格
・用途別市場規模（細胞がん、固形腫瘍）
- 抗TIGIT抗体の用途別販売量
- 抗TIGIT抗体の用途別売上
- 抗TIGIT抗体の用途別価格
・北米市場
- 北米の抗TIGIT抗体市場規模（種類別、用途別）
- 主要国別の抗TIGIT抗体市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの抗TIGIT抗体市場規模（種類別、用途別）
- 主要国別の抗TIGIT抗体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の抗TIGIT抗体市場規模（種類別、用途別）
- 主要国別の抗TIGIT抗体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の抗TIGIT抗体市場規模（種類別、用途別）
- 主要国別の抗TIGIT抗体市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの抗TIGIT抗体市場規模（種類別、用途別）
- 主要国別の抗TIGIT抗体市場規模（トルコ、サウジアラビア）
・企業情報
Roche、Merck、AstraZeneca、Arcus、Astellas、BeiGene、BMS、Junshi Biosciences、Innovent Biologics、Mereo BioPharma、Seattle Genetics、Hengrui Medicine、Compugen
・産業チェーン及び販売チャネル分析
- 抗TIGIT抗体の産業チェーン分析
- 抗TIGIT抗体の原材料
- 抗TIGIT抗体の生産プロセス
- 抗TIGIT抗体の販売及びマーケティング
- 抗TIGIT抗体の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 抗TIGIT抗体の産業動向
- 抗TIGIT抗体のマーケットドライバー
- 抗TIGIT抗体の課題
- 抗TIGIT抗体の阻害要因
・主な調査結果

A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
Market Analysis and Insights: Global Anti-TIGIT Antibody Market
The global Anti-TIGIT Antibody market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Monotherapy accounting for % of the Anti-TIGIT Antibody global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cell Carcinoma segment is altered to an % CAGR throughout this forecast period.
China Anti-TIGIT Antibody market size is valued at US$ million in 2021, while the North America and Europe Anti-TIGIT Antibody are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anti-TIGIT Antibody landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-TIGIT Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-TIGIT Antibody market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-TIGIT Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-TIGIT Antibody market.
Global Anti-TIGIT Antibody Scope and Market Size
Anti-TIGIT Antibody market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anti-TIGIT Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Cell Carcinoma
Solid Tumor
By Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-TIGIT Antibody Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Anti-TIGIT Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-TIGIT Antibody Market Perspective (2017-2028)
2.2 Anti-TIGIT Antibody Growth Trends by Region
2.2.1 Anti-TIGIT Antibody Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-TIGIT Antibody Historic Market Size by Region (2017-2022)
2.2.3 Anti-TIGIT Antibody Forecasted Market Size by Region (2023-2028)
2.3 Anti-TIGIT Antibody Market Dynamics
2.3.1 Anti-TIGIT Antibody Industry Trends
2.3.2 Anti-TIGIT Antibody Market Drivers
2.3.3 Anti-TIGIT Antibody Market Challenges
2.3.4 Anti-TIGIT Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-TIGIT Antibody Players by Revenue
3.1.1 Global Top Anti-TIGIT Antibody Players by Revenue (2017-2022)
3.1.2 Global Anti-TIGIT Antibody Revenue Market Share by Players (2017-2022)
3.2 Global Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-TIGIT Antibody Revenue
3.4 Global Anti-TIGIT Antibody Market Concentration Ratio
3.4.1 Global Anti-TIGIT Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-TIGIT Antibody Revenue in 2021
3.5 Anti-TIGIT Antibody Key Players Head office and Area Served
3.6 Key Players Anti-TIGIT Antibody Product Solution and Service
3.7 Date of Enter into Anti-TIGIT Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-TIGIT Antibody Breakdown Data by Type
4.1 Global Anti-TIGIT Antibody Historic Market Size by Type (2017-2022)
4.2 Global Anti-TIGIT Antibody Forecasted Market Size by Type (2023-2028)
5 Anti-TIGIT Antibody Breakdown Data by Application
5.1 Global Anti-TIGIT Antibody Historic Market Size by Application (2017-2022)
5.2 Global Anti-TIGIT Antibody Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-TIGIT Antibody Market Size (2017-2028)
6.2 North America Anti-TIGIT Antibody Market Size by Type
6.2.1 North America Anti-TIGIT Antibody Market Size by Type (2017-2022)
6.2.2 North America Anti-TIGIT Antibody Market Size by Type (2023-2028)
6.2.3 North America Anti-TIGIT Antibody Market Share by Type (2017-2028)
6.3 North America Anti-TIGIT Antibody Market Size by Application
6.3.1 North America Anti-TIGIT Antibody Market Size by Application (2017-2022)
6.3.2 North America Anti-TIGIT Antibody Market Size by Application (2023-2028)
6.3.3 North America Anti-TIGIT Antibody Market Share by Application (2017-2028)
6.4 North America Anti-TIGIT Antibody Market Size by Country
6.4.1 North America Anti-TIGIT Antibody Market Size by Country (2017-2022)
6.4.2 North America Anti-TIGIT Antibody Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-TIGIT Antibody Market Size (2017-2028)
7.2 Europe Anti-TIGIT Antibody Market Size by Type
7.2.1 Europe Anti-TIGIT Antibody Market Size by Type (2017-2022)
7.2.2 Europe Anti-TIGIT Antibody Market Size by Type (2023-2028)
7.2.3 Europe Anti-TIGIT Antibody Market Share by Type (2017-2028)
7.3 Europe Anti-TIGIT Antibody Market Size by Application
7.3.1 Europe Anti-TIGIT Antibody Market Size by Application (2017-2022)
7.3.2 Europe Anti-TIGIT Antibody Market Size by Application (2023-2028)
7.3.3 Europe Anti-TIGIT Antibody Market Share by Application (2017-2028)
7.4 Europe Anti-TIGIT Antibody Market Size by Country
7.4.1 Europe Anti-TIGIT Antibody Market Size by Country (2017-2022)
7.4.2 Europe Anti-TIGIT Antibody Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-TIGIT Antibody Market Size (2017-2028)
8.2 Asia-Pacific Anti-TIGIT Antibody Market Size by Type
8.2.1 Asia-Pacific Anti-TIGIT Antibody Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-TIGIT Antibody Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-TIGIT Antibody Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-TIGIT Antibody Market Size by Application
8.3.1 Asia-Pacific Anti-TIGIT Antibody Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-TIGIT Antibody Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-TIGIT Antibody Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-TIGIT Antibody Market Size by Region
8.4.1 Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-TIGIT Antibody Market Size (2017-2028)
9.2 Latin America Anti-TIGIT Antibody Market Size by Type
9.2.1 Latin America Anti-TIGIT Antibody Market Size by Type (2017-2022)
9.2.2 Latin America Anti-TIGIT Antibody Market Size by Type (2023-2028)
9.2.3 Latin America Anti-TIGIT Antibody Market Share by Type (2017-2028)
9.3 Latin America Anti-TIGIT Antibody Market Size by Application
9.3.1 Latin America Anti-TIGIT Antibody Market Size by Application (2017-2022)
9.3.2 Latin America Anti-TIGIT Antibody Market Size by Application (2023-2028)
9.3.3 Latin America Anti-TIGIT Antibody Market Share by Application (2017-2028)
9.4 Latin America Anti-TIGIT Antibody Market Size by Country
9.4.1 Latin America Anti-TIGIT Antibody Market Size by Country (2017-2022)
9.4.2 Latin America Anti-TIGIT Antibody Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-TIGIT Antibody Market Size (2017-2028)
10.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Type
10.2.1 Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-TIGIT Antibody Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-TIGIT Antibody Market Size by Application
10.3.1 Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-TIGIT Antibody Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-TIGIT Antibody Market Size by Country
10.4.1 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Anti-TIGIT Antibody Introduction
11.1.4 Roche Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Anti-TIGIT Antibody Introduction
11.2.4 Merck Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anti-TIGIT Antibody Introduction
11.3.4 AstraZeneca Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 Arcus
11.4.1 Arcus Company Details
11.4.2 Arcus Business Overview
11.4.3 Arcus Anti-TIGIT Antibody Introduction
11.4.4 Arcus Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.4.5 Arcus Recent Developments
11.5 Astellas
11.5.1 Astellas Company Details
11.5.2 Astellas Business Overview
11.5.3 Astellas Anti-TIGIT Antibody Introduction
11.5.4 Astellas Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.5.5 Astellas Recent Developments
11.6 BeiGene
11.6.1 BeiGene Company Details
11.6.2 BeiGene Business Overview
11.6.3 BeiGene Anti-TIGIT Antibody Introduction
11.6.4 BeiGene Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.6.5 BeiGene Recent Developments
11.7 BMS
11.7.1 BMS Company Details
11.7.2 BMS Business Overview
11.7.3 BMS Anti-TIGIT Antibody Introduction
11.7.4 BMS Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.7.5 BMS Recent Developments
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Details
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences Anti-TIGIT Antibody Introduction
11.8.4 Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.8.5 Junshi Biosciences Recent Developments
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Details
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics Anti-TIGIT Antibody Introduction
11.9.4 Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.9.5 Innovent Biologics Recent Developments
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Details
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma Anti-TIGIT Antibody Introduction
11.10.4 Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.10.5 Mereo BioPharma Recent Developments
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Details
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics Anti-TIGIT Antibody Introduction
11.11.4 Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.11.5 Seattle Genetics Recent Developments
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Details
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Anti-TIGIT Antibody Introduction
11.12.4 Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.12.5 Hengrui Medicine Recent Developments
11.13 Compugen
11.13.1 Compugen Company Details
11.13.2 Compugen Business Overview
11.13.3 Compugen Anti-TIGIT Antibody Introduction
11.13.4 Compugen Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.13.5 Compugen Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Anti-TIGIT Antibody Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Anti-TIGIT Antibody Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Anti-TIGIT Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-TIGIT Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anti-TIGIT Antibody Market Share by Region (2017-2022)
Table 8. Global Anti-TIGIT Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anti-TIGIT Antibody Market Share by Region (2023-2028)
Table 10. Anti-TIGIT Antibody Market Trends
Table 11. Anti-TIGIT Antibody Market Drivers
Table 12. Anti-TIGIT Antibody Market Challenges
Table 13. Anti-TIGIT Antibody Market Restraints
Table 14. Global Anti-TIGIT Antibody Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anti-TIGIT Antibody Revenue Share by Players (2017-2022)
Table 16. Global Top Anti-TIGIT Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2021)
Table 17. Ranking of Global Top Anti-TIGIT Antibody Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anti-TIGIT Antibody Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-TIGIT Antibody Product Solution and Service
Table 21. Date of Enter into Anti-TIGIT Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anti-TIGIT Antibody Revenue Market Share by Type (2017-2022)
Table 25. Global Anti-TIGIT Antibody Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anti-TIGIT Antibody Revenue Market Share by Type (2023-2028)
Table 27. Global Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Anti-TIGIT Antibody Revenue Share by Application (2017-2022)
Table 29. Global Anti-TIGIT Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Anti-TIGIT Antibody Revenue Share by Application (2023-2028)
Table 31. North America Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Anti-TIGIT Antibody Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Anti-TIGIT Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Anti-TIGIT Antibody Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Anti-TIGIT Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Anti-TIGIT Antibody Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Anti-TIGIT Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Anti-TIGIT Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Anti-TIGIT Antibody Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Anti-TIGIT Antibody Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Anti-TIGIT Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Anti-TIGIT Antibody Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Anti-TIGIT Antibody Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Anti-TIGIT Antibody Product
Table 64. Roche Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Developments
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Anti-TIGIT Antibody Product
Table 69. Merck Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 70. Merck Recent Developments
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Anti-TIGIT Antibody Product
Table 74. AstraZeneca Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 75. AstraZeneca Recent Developments
Table 76. Arcus Company Details
Table 77. Arcus Business Overview
Table 78. Arcus Anti-TIGIT Antibody Product
Table 79. Arcus Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 80. Arcus Recent Developments
Table 81. Astellas Company Details
Table 82. Astellas Business Overview
Table 83. Astellas Anti-TIGIT Antibody Product
Table 84. Astellas Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 85. Astellas Recent Developments
Table 86. BeiGene Company Details
Table 87. BeiGene Business Overview
Table 88. BeiGene Anti-TIGIT Antibody Product
Table 89. BeiGene Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 90. BeiGene Recent Developments
Table 91. BMS Company Details
Table 92. BMS Business Overview
Table 93. BMS Anti-TIGIT Antibody Product
Table 94. BMS Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 95. BMS Recent Developments
Table 96. Junshi Biosciences Company Details
Table 97. Junshi Biosciences Business Overview
Table 98. Junshi Biosciences Anti-TIGIT Antibody Product
Table 99. Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 100. Junshi Biosciences Recent Developments
Table 101. Innovent Biologics Company Details
Table 102. Innovent Biologics Business Overview
Table 103. Innovent Biologics Anti-TIGIT Antibody Product
Table 104. Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 105. Innovent Biologics Recent Developments
Table 106. Mereo BioPharma Company Details
Table 107. Mereo BioPharma Business Overview
Table 108. Mereo BioPharma Anti-TIGIT Antibody Product
Table 109. Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 110. Mereo BioPharma Recent Developments
Table 111. Seattle Genetics Company Details
Table 112. Seattle Genetics Business Overview
Table 113. Seattle Genetics Anti-TIGIT Antibody Product
Table 114. Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 115. Seattle Genetics Recent Developments
Table 116. Hengrui Medicine Company Details
Table 117. Hengrui Medicine Business Overview
Table 118. Hengrui Medicine Anti-TIGIT Antibody Product
Table 119. Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 120. Hengrui Medicine Recent Developments
Table 121. Compugen Company Details
Table 122. Compugen Business Overview
Table 123. Compugen Anti-TIGIT Antibody Product
Table 124. Compugen Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 125. Compugen Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-TIGIT Antibody Market Share by Type: 2021 VS 2028
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Anti-TIGIT Antibody Market Share by Application: 2021 VS 2028
Figure 5. Cell Carcinoma Case Studies
Figure 6. Solid Tumor Case Studies
Figure 7. Anti-TIGIT Antibody Report Years Considered
Figure 8. Global Anti-TIGIT Antibody Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Anti-TIGIT Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Anti-TIGIT Antibody Market Share by Region: 2021 VS 2028
Figure 11. Global Anti-TIGIT Antibody Market Share by Players in 2021
Figure 12. Global Top Anti-TIGIT Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Anti-TIGIT Antibody Revenue in 2021
Figure 14. North America Anti-TIGIT Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Anti-TIGIT Antibody Market Size Market Share by Type (2017-2028)
Figure 16. North America Anti-TIGIT Antibody Market Size Market Share by Application (2017-2028)
Figure 17. North America Anti-TIGIT Antibody Market Size Share by Country (2017-2028)
Figure 18. United States Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Anti-TIGIT Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Anti-TIGIT Antibody Market Size Market Share by Type (2017-2028)
Figure 22. Europe Anti-TIGIT Antibody Market Size Market Share by Application (2017-2028)
Figure 23. Europe Anti-TIGIT Antibody Market Size Share by Country (2017-2028)
Figure 24. Germany Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Anti-TIGIT Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Anti-TIGIT Antibody Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Anti-TIGIT Antibody Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Anti-TIGIT Antibody Market Size Share by Region (2017-2028)
Figure 34. China Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Anti-TIGIT Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Anti-TIGIT Antibody Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Anti-TIGIT Antibody Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Anti-TIGIT Antibody Market Size Share by Country (2017-2028)
Figure 44. Mexico Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Anti-TIGIT Antibody Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Anti-TIGIT Antibody Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Anti-TIGIT Antibody Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Anti-TIGIT Antibody Market Size Share by Country (2017-2028)
Figure 50. Turkey Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Roche Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 54. Merck Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 55. AstraZeneca Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 56. Arcus Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 57. Astellas Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 58. BeiGene Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 59. BMS Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 60. Junshi Biosciences Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 61. Innovent Biologics Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 62. Mereo BioPharma Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 63. Seattle Genetics Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 64. Hengrui Medicine Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 65. Compugen Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

抗幼若ホルモンのグローバル市場インサイト・予測（～2028年）

Global Anti Juvenile Hormone Market Insights and Forecast to 2028
QY2203B09232 2022年3月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界の抗幼若ホルモンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗幼若ホルモンの世界市...

盗難防止ウィンドウのグローバル市場インサイト・予測（～2028年）

Global Anti-theft Window Market Insights and Forecast to 2028
QY2203B12793 2022年3月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界の盗難防止ウィンドウの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に盗難防止ウィンドウ...

デオキシコール酸ナトリウムのグローバル市場インサイト・予測（～2028年）

Global Sodium Deoxycholate Market Insights, Forecast to 2028
QY2203B04182 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のデオキシコール酸ナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にデオキシコ...

クラウドコンピューティングスタックレイヤーのグローバル市場インサイト・予測（～2028年）

Global Cloud Computing Stack Layers Market Insights and Forecast to 2028
QY2203B02533 2022年3月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のクラウドコンピューティングスタックレイヤーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

N,N,N-トリメチルボラジンのグローバル市場インサイト・予測（～2028年）

Global N,N,N-Trimethylborazine Market Insights and Forecast to 2028
QY2203B00860 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のN,N,N-トリメチルボラジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN,N...

リチウムイオン電池材料のグローバル市場インサイト・予測（～2028年）

Global Lithium-ion Battery Materials Market Insights and Forecast to 2028
QY2203B06987 2022年3月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のリチウムイオン電池材料の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリチウムイオン...

冷凍機用ガスケットのグローバル市場インサイト・予測（～2028年）

Global Refrigerator Gasket Market Insights, Forecast to 2028
QY2203B14262 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界の冷凍機用ガスケットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に冷凍機用ガスケット...

2,2′-ビス(トリフルオロメチル)ベンジジンのグローバル市場インサイト・予測（～2028年）

Global 2,2'-Bis(trifluoromethyl)benzidine Market Insights, Forecast to 2028
QY2203B00069 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の2,2'-ビス(トリフルオロメチル)ベンジジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2...

ヒプロメロースフタレートのグローバル市場インサイト・予測（～2028年）

Global Hypromellose Phthalate Market Insights and Forecast to 2028
QY2203B05209 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のヒプロメロースフタレートの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒプロメロー...

カルボプラチンのグローバル市場インサイト・予測（～2028年）

Global Carboplatin Market Insights and Forecast to 2028
QY2203B02393 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のカルボプラチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカルボプラチンの世界市...

盗難防止ウィンドウのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Anti-theft Window Market Due to the COVID-19 pandemic, the global Anti-theft Window market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering t…
抗幼若ホルモンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Anti Juvenile Hormone Market Due to the COVID-19 pandemic, the global Anti Juvenile Hormone market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully consi…
クラウドコンピューティングスタックレイヤーのグローバル市場インサイト・予測（～2028年） Cloud computing describes wide range of useful services. For example, cloud computing allows you to move compute and data services off-site to a location-transparent facility. Cloud-based data can be made accessible via the Internet anytime, anywhere and is often less costly than locally hosted data…
リチウムイオン電池材料のグローバル市場インサイト・予測（～2028年） Li-ion batteries consist of largely four main components: cathode, anode, electrolyte, and separator. The Lithium-ion Battery Materials industry can be broken down into several segments, Cathode Material, Anode Materials, etc. Across the world, the major players cover Umicore, Targray, etc. Market A…
スキー用品・アパレルのグローバル市場インサイト・予測（～2028年） Skier Equipment and Apparel refers to the gear used by a skier in Skiing sport, which include Skis & Snowboard, Ski Boots, Ski Apparel, Ski Protection and others. Market Analysis and Insights: Global Skier Equipment and Apparel Market The global Skier Equipment and Apparel market size is projected t…